• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非离子型水溶性造影剂碘帕醇的脊髓造影:并发症发生率

Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.

作者信息

Bassi P, Cecchini A, Dettori P, Signorini E

出版信息

Neuroradiology. 1982;24(2):85-90. doi: 10.1007/BF00339196.

DOI:10.1007/BF00339196
PMID:7177375
Abstract

A review of immediate and delayed side effects noted in a consecutive series of 1,138 myelograms made with Iopamidol in the Services of Neuroradiology of various hospitals and university clinics at Pavia, Perugia, Vicenza, and Parma (all in Italy). The contrast was administered by lumbar spinal route at iodine concentrations of 200, 300 and 370 mg/ml, in amounts varying from 5 to 20 ml depending on segments being examined and extant clinical indications. The incidence and characteristics of complications (headache, nausea, vomiting, evidence of radicular irritation, etc.) were assessed in relation to examination technics, segments of spine being explored, iodine concentrations, and amounts of contrast injected.

摘要

对帕维亚、佩鲁贾、维琴察和帕尔马(均位于意大利)各医院及大学诊所神经放射科连续进行的1138例使用碘帕醇的脊髓造影所记录的即时和延迟副作用进行综述。造影剂通过腰椎途径给药,碘浓度分别为200、300和370mg/ml,根据检查节段和现有临床指征,用量从5至20ml不等。根据检查技术、所探查的脊柱节段、碘浓度和注入的造影剂用量,评估并发症(头痛、恶心、呕吐、神经根刺激迹象等)的发生率和特征。

相似文献

1
Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.使用非离子型水溶性造影剂碘帕醇的脊髓造影:并发症发生率
Neuroradiology. 1982;24(2):85-90. doi: 10.1007/BF00339196.
2
Clinical experience with iopamidol for myelography.碘帕醇用于脊髓造影的临床经验。
AJNR Am J Neuroradiol. 1983 May-Jun;4(3):314-6.
3
Iopamidol (B 15000), a nonionic water-soluble contrast medium for neuroradiology. Part I: Results of a clinical trial for myelography.碘帕醇(B 15000),一种用于神经放射学的非离子型水溶性造影剂。第一部分:脊髓造影临床试验结果。
Neuroradiology. 1982;23(2):81-4. doi: 10.1007/BF00367241.
4
Iopamidol in lumbar myelography.碘帕醇在腰椎脊髓造影中的应用。
Surg Neurol. 1983 Aug;20(2):165-70. doi: 10.1016/0090-3019(83)90471-8.
5
[Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
Radiol Med. 1980 Apr;66(4):203-10.
6
Outpatient lumbar myelography. Analysis of complications after myelography comparing outpatients with inpatients.门诊腰椎脊髓造影。脊髓造影后并发症分析:门诊患者与住院患者对比。
Spine (Phila Pa 1976). 1985 Jul-Aug;10(6):567-70.
7
Iohexol vs. iopamidol for myelography.
Invest Radiol. 1985 Jan-Feb;20(1 Suppl):S37-43. doi: 10.1097/00004424-198501002-00010.
8
Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.鞘内注射碘帕醇和甲泛葡胺用于腰椎脊髓造影毒性的双盲研究。
J Can Assoc Radiol. 1984 Sep;35(3):257-8.
9
Critical evaluation of a new water soluble contrast medium (Iopamidolo) in cervical myelograms.新型水溶性造影剂(碘帕醇)用于颈椎脊髓造影的批判性评估。
J Neurosurg Sci. 1982 Jul-Sep;26(3):169-72.
10
A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
J Neurosurg. 1983 Apr;58(4):531-7. doi: 10.3171/jns.1983.58.4.0531.

引用本文的文献

1
Potential Inhibitors of SARS-CoV-2 Main Protease (M) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies.通过分子对接研究从美国食品药品监督管理局(FDA)批准的药物库中鉴定出的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶(M)的潜在抑制剂。
Biomedicines. 2022 Dec 29;11(1):85. doi: 10.3390/biomedicines11010085.
2
Critical Assessment of Myelography Practices: A Call for Rational Guideline Revision.脊髓造影术实践的批判性评估:呼吁修订合理的指南。
AJNR Am J Neuroradiol. 2018 Dec;39(12):2378-2384. doi: 10.3174/ajnr.A5867. Epub 2018 Nov 1.
3
Outpatient Myelography: A Prospective Trial Comparing Complications after Myelography between Outpatients and Inpatients in Japan.

本文引用的文献

1
[Cervical myelography with water-soluble nonionic contrast media (metrizamide and iopamidol) (author's transl)].
Radiol Med. 1980 Apr;66(4):211-4.
2
Cervical myelography with iopamidolo.碘帕醇脊髓造影术。
Neuroradiology. 1981 Mar;21(2):97-9. doi: 10.1007/BF00342988.
3
[Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
Radiol Med. 1980 Apr;66(4):203-10.
4
门诊脊髓造影:一项比较日本门诊患者和住院患者脊髓造影后并发症的前瞻性试验。
Asian Spine J. 2015 Dec;9(6):928-34. doi: 10.4184/asj.2015.9.6.928. Epub 2015 Dec 8.
4
Cerebral venous thrombosis after myelography with iopamidol.
Neuroradiology. 1996 Aug;38(6):534-6. doi: 10.1007/BF00626091.
5
Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.使用甲泛葡胺和碘帕醇进行脊髓造影后精神障碍的心理测量学证明与量化。
Neuroradiology. 1984;26(3):229-33. doi: 10.1007/BF00342419.
6
Direct puncture versus run up cervical myelography with iopamidol: a comparison of side effects, EEG changes and radiographic quality.碘帕醇直接穿刺与上行性颈椎脊髓造影:副作用、脑电图变化及影像学质量的比较
J Neurol Neurosurg Psychiatry. 1983 Oct;46(10):959-62. doi: 10.1136/jnnp.46.10.959.
7
Radiculography with reduced amounts of contrast medium.使用少量造影剂的神经根造影术。
Acta Neurochir (Wien). 1984;73(3-4):223-8. doi: 10.1007/BF01400856.
8
Routine bed rest is unnecessary after cervical myelography.
Neuroradiology. 1985;27(3):214-6. doi: 10.1007/BF00344490.
9
Large volume full columnar lumbar myelography.大容量全柱状腰椎脊髓造影。
Neuroradiology. 1987;29(4):371-3. doi: 10.1007/BF00348917.
10
Iohexol in paediatric myelography. An open non-comparative trial.碘海醇在儿科脊髓造影中的应用。一项开放性非对照试验。
Neuroradiology. 1986;28(1):65-8. doi: 10.1007/BF00341769.
Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
碘帕醇,一种用于神经放射学的新型非离子水溶性造影剂。
Neuroradiology. 1980 Apr;19(3):119-21. doi: 10.1007/BF00342385.
5
[Contrast media in use in myelography and ventriculography: current status and future prospects].[脊髓造影和脑室造影中使用的造影剂:现状与未来展望]
Radiol Med. 1980 Apr;66(4):195-202.
6
Contrast agent design. Some aspects on the synthesis of water soluble contrast agents of low osmolality.造影剂设计。低渗水溶性造影剂合成的若干方面。
J Theor Biol. 1969 Aug;24(2):216-26. doi: 10.1016/s0022-5193(69)80047-0.
7
Long term side effects after myelography with watersoluble contrast media: Conturex, Conray Meglumin 282 and Dimer-X.水溶性造影剂脊髓造影后的长期副作用:康锐克斯、康瑞( meglumine 282)和二聚体-X。
Neuroradiology. 1973 Dec;6(4):206-11. doi: 10.1007/BF00335325.
8
Metrizamide as contrast medium for myelography and ventriculography. Preliminary clinical experiences.甲泛葡胺作为脊髓造影和脑室造影的造影剂。初步临床经验。
Acta Radiol Suppl. 1973;335:346-58. doi: 10.1177/0284185173014s33543.
9
Lumbar myelography with metrizamide.用甲泛葡胺进行腰椎脊髓造影。
Acta Radiol Suppl. 1973;335:367-79. doi: 10.1177/0284185173014s33545.
10
Hyperosmolality of the cerebrospinal fluid as a cause of adhesive arachnoiditis in lumbar myelography.脑脊液高渗作为腰椎脊髓造影中粘连性蛛网膜炎的一个病因。
Acta Radiol Diagn (Stockh). 1974 Nov;15(6):619-29. doi: 10.1177/028418517401500604.